1981
DOI: 10.1016/s0140-6736(81)91965-6
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin and Senile Cataracts in Rheumatoid Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
24
0

Year Published

1987
1987
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(25 citation statements)
references
References 0 publications
1
24
0
Order By: Relevance
“…Orally administrated nonsteroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) have been proposed to protect against, as well as represent a risk factor for, cataract [1][2][3][4] . NSAIDs are used for their ability to reduce inflammation, pain and fever by inhibition of the enzyme cyclooxygenase (COX).…”
Section: Introductionmentioning
confidence: 99%
“…Orally administrated nonsteroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid (ASA) have been proposed to protect against, as well as represent a risk factor for, cataract [1][2][3][4] . NSAIDs are used for their ability to reduce inflammation, pain and fever by inhibition of the enzyme cyclooxygenase (COX).…”
Section: Introductionmentioning
confidence: 99%
“…This 4 study found that aspirin is associated with significantly lower odds of cataract development. The proposed mechanism of aspirin mediated protection against cataract formation is not known, however studies have shown that lowering plasma tryptophan levels and reduced aldose reductase activity may be involved [39]. Further, the use of allopurinol suggested that it may be a risk factor for cataract formation [40].…”
Section: Discussionmentioning
confidence: 99%
“…Aspirin is unique among conventional nonsteroid anti-inflammatory drugs [16] . It has been reported earlier that aspirin may limit steroid-induced lens opacity in humans [17] . Numerous epidemiological and laboratory studies have demonstrated that aspirin can protect against the development of cataract, ischemic heart disease, stroke, Alzheimer's disease, colorectal cancer, and prostate cancer [18,19] .…”
mentioning
confidence: 81%